Home › Compare › IMRFF vs JNJ

IMRFF vs JNJ: Dividend Comparison 2026

IMRFF yields 3005.26% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMRFF wins by $462298228459.91M in total portfolio value
10 years
IMRFF
IMRFF
● Live price
3005.26%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$462298228459.93M
Annual income
$433,896,670,820,452,160.00
Full IMRFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — IMRFF vs JNJ

📍 IMRFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMRFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMRFF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IMRFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMRFF
Annual income on $10K today (after 15% tax)
$255,447.03/yr
After 10yr DRIP, annual income (after tax)
$368,812,170,197,384,300.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, IMRFF beats the other by $368,812,170,197,383,600.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMRFF + JNJ for your $10,000?

IMRFF: 50%JNJ: 50%
100% JNJ50/50100% IMRFF
Portfolio after 10yr
$231149114229.97M
Annual income
$216,948,335,410,226,500.00/yr
Blended yield
93.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IMRFF
No analyst data
Altman Z
-8.9
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMRFF buys
0
JNJ buys
0
No recent congressional trades found for IMRFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMRFFJNJ
Forward yield3005.26% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$462298228459.93M ✓$20.0K
Annual income after 10y$433,896,670,820,452,160.00 ✓$827.78
Total dividends collected$460334766592.62M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IMRFF vs JNJ ($10,000, DRIP)

YearIMRFF PortfolioIMRFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$311,226$300,525.92$10,676$355.77+$300.6K → IMRFF
2$9,074,269$8,741,257.58$11,407$389.39+$9.06M → IMRFF
3$247,900,851$238,191,382.55$12,198$426.53+$247.89M → IMRFF
4$6,346,724,628$6,081,470,717.53$13,056$467.62+$6346.71M → IMRFF
5$152,302,214,908$145,511,219,556.27$13,987$513.12+$152302.20M → IMRFF
6$3,426,355,536,268$3,263,392,166,316.16$14,998$563.56+$3426355.52M → IMRFF
7$72,280,035,664,157$68,613,835,240,350.64$16,098$619.52+$72280035.65M → IMRFF
8$1,430,078,137,131,734$1,352,738,498,971,085.50$17,295$681.69+$1430078137.11M → IMRFF
9$26,543,511,812,593,556$25,013,328,205,862,600.00$18,599$750.82+$26543511812.57M → IMRFF
10$462,298,228,459,927,300$433,896,670,820,452,160.00$20,022$827.78+$462298228459.91M → IMRFF

IMRFF vs JNJ: Complete Analysis 2026

IMRFF — Stock

iMetal Resources Inc., a junior exploration company, focuses on the acquisition, exploration, development, and evaluation of resource properties in Ontario and Quebec in Canada. The company explores for precious and base metal resources. Its flagship property is the Gowganda West project covering an area of approximately 147 squares kilometers located in Ontario; Kerrs Gold property covering an area of 665 hectares located in Ontario; and Ghost Mountain property consists of eleven claim units covering an area of 220 hectares located in Ontario. The company also holds 100% interest in the Carheil project encompasses approximately 5,400 acres of contiguous land located in the Abitibi region of Quebec. The company was formerly known as Adroit Resources Inc. and changed its name to iMetal Resources Inc. in November 2015. iMetal Resources Inc. was incorporated in 1993 and is headquartered in Vancouver, Canada.

Full IMRFF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this IMRFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMRFF vs SCHDIMRFF vs JEPIIMRFF vs OIMRFF vs KOIMRFF vs MAINIMRFF vs ABBVIMRFF vs MRKIMRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.